Figure 1From: Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic controlKaplan-Meier survival analyses for major adverse cardiovascular event during follow-up according to the plasma ADMA tertiles. P values by log-rank test are shown.Back to article page